Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 246

1.

Effect of Daisaikoto on Expressions of SIRT1 and NF-kappaB of Diabetic Fatty Liver Rats Induced by High-Fat Diet and Streptozotocin.

Qian W, Cai X, Zhang X, Wang Y, Qian Q, Hasegawa J.

Yonago Acta Med. 2016 Jun 29;59(2):149-58. eCollection 2016 Jun.

2.

Sirt1 decreased adipose inflammation by interacting with Akt2 and inhibiting mTOR/S6K1 pathway in mice.

Liu Z, Gan L, Liu G, Chen Y, Wu T, Feng F, Sun C.

J Lipid Res. 2016 Aug;57(8):1373-81. doi: 10.1194/jlr.M063537. Epub 2016 Jun 17.

PMID:
27317762
3.

Olive Leaf Extract from Sicilian Cultivar Reduced Lipid Accumulation by Inducing Thermogenic Pathway during Adipogenesis.

Palmeri R, Monteleone JI, Spagna G, Restuccia C, Raffaele M, Vanella L, Li Volti G, Barbagallo I.

Front Pharmacol. 2016 May 31;7:143. doi: 10.3389/fphar.2016.00143. eCollection 2016.

4.

Nutraceutical Properties of Olive Oil Polyphenols. An Itinerary from Cultured Cells through Animal Models to Humans.

Rigacci S, Stefani M.

Int J Mol Sci. 2016 May 31;17(6). pii: E843. doi: 10.3390/ijms17060843. Review.

5.

Sirtuin activation as a therapeutic approach against inborn errors of metabolism.

Bleeker JC, Houtkooper RH.

J Inherit Metab Dis. 2016 Jul;39(4):565-72. doi: 10.1007/s10545-016-9939-8. Epub 2016 May 4.

6.

In Search of New Therapeutic Targets in Obesity Treatment: Sirtuins.

Kurylowicz A.

Int J Mol Sci. 2016 Apr 19;17(4). pii: E572. doi: 10.3390/ijms17040572. Review.

7.

Dietary proanthocyanidins boost hepatic NAD(+) metabolism and SIRT1 expression and activity in a dose-dependent manner in healthy rats.

Aragonès G, Suárez M, Ardid-Ruiz A, Vinaixa M, Rodríguez MA, Correig X, Arola L, Bladé C.

Sci Rep. 2016 Apr 22;6:24977. doi: 10.1038/srep24977.

8.

Resveratrol enhances HBV replication through activating Sirt1-PGC-1α-PPARα pathway.

Shi Y, Li Y, Huang C, Ying L, Xue J, Wu H, Chen Z, Yang Z.

Sci Rep. 2016 Apr 21;6:24744. doi: 10.1038/srep24744.

9.

Arachidonic and oleic acid exert distinct effects on the DNA methylome.

Silva-Martínez GA, Rodríguez-Ríos D, Alvarado-Caudillo Y, Vaquero A, Esteller M, Carmona FJ, Moran S, Nielsen FC, Wickström-Lindholm M, Wrobel K, Wrobel K, Barbosa-Sabanero G, Zaina S, Lund G.

Epigenetics. 2016 May 3;11(5):321-34. doi: 10.1080/15592294.2016.1161873. Epub 2016 Apr 18.

PMID:
27088456
10.

Autophagy in Ischemic Livers: A Critical Role of Sirtuin 1/Mitofusin 2 Axis in Autophagy Induction.

Chun SK, Go K, Yang MJ, Zendejas I, Behrns KE, Kim JS.

Toxicol Res. 2016 Jan;32(1):35-46. doi: 10.5487/TR.2016.32.1.035. Epub 2016 Jan 31.

11.

Linking Pathogenic Mechanisms of Alcoholic Liver Disease With Clinical Phenotypes.

Nagy LE, Ding WX, Cresci G, Saikia P, Shah VH.

Gastroenterology. 2016 Jun;150(8):1756-68. doi: 10.1053/j.gastro.2016.02.035. Epub 2016 Feb 23.

PMID:
26919968
12.

Sirtuins Link Inflammation and Metabolism.

Vachharajani VT, Liu T, Wang X, Hoth JJ, Yoza BK, McCall CE.

J Immunol Res. 2016;2016:8167273. doi: 10.1155/2016/8167273. Epub 2016 Jan 20. Review.

13.

SIRT1 Disruption in Human Fetal Hepatocytes Leads to Increased Accumulation of Glucose and Lipids.

Tobita T, Guzman-Lepe J, Takeishi K, Nakao T, Wang Y, Meng F, Deng CX, Collin de l'Hortet A, Soto-Gutierrez A.

PLoS One. 2016 Feb 18;11(2):e0149344. doi: 10.1371/journal.pone.0149344. eCollection 2016.

14.

Circadian variations in the liver metabolites of medaka (Oryzias latipes).

Fujisawa K, Takami T, Kimoto Y, Matsumoto T, Yamamoto N, Terai S, Sakaida I.

Sci Rep. 2016 Feb 10;6:20916. doi: 10.1038/srep20916.

15.

Evolving roles of circadian rhythms in liver homeostasis and pathology.

Zhou D, Wang Y, Chen L, Jia L, Yuan J, Sun M, Zhang W, Wang P, Zuo J, Xu Z, Luan J.

Oncotarget. 2016 Feb 23;7(8):8625-39. doi: 10.18632/oncotarget.7065. Review.

16.

Silibinin Regulates Lipid Metabolism and Differentiation in Functional Human Adipocytes.

Barbagallo I, Vanella L, Cambria MT, Tibullo D, Godos J, Guarnaccia L, Zappalà A, Galvano F, Li Volti G.

Front Pharmacol. 2016 Jan 21;6:309. doi: 10.3389/fphar.2015.00309. eCollection 2015.

17.
18.

PPARα Agonist WY-14643 Induces SIRT1 Activity in Rat Fatty Liver Ischemia-Reperfusion Injury.

Pantazi E, Folch-Puy E, Bejaoui M, Panisello A, Varela AT, Rolo AP, Palmeira CM, Roselló-Catafau J.

Biomed Res Int. 2015;2015:894679. doi: 10.1155/2015/894679. Epub 2015 Oct 11.

19.

Inhibition of HMGB1 release via salvianolic acid B-mediated SIRT1 up-regulation protects rats against non-alcoholic fatty liver disease.

Zeng W, Shan W, Gao L, Gao D, Hu Y, Wang G, Zhang N, Li Z, Tian X, Xu W, Peng J, Ma X, Yao J.

Sci Rep. 2015 Nov 3;5:16013. doi: 10.1038/srep16013.

20.

Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes.

DiNicolantonio JJ, Bhutani J, O'Keefe JH.

Open Heart. 2015 Oct 19;2(1):e000327. doi: 10.1136/openhrt-2015-000327. eCollection 2015. Review.

Items per page

Supplemental Content

Write to the Help Desk